-Sherene S Min Researcher Activity Profile

Research Author Detailed Information 

Sherene S Min Publication Rate By Year

Sherene S Min has published 2 paper(s) in 2007, 3 paper(s) in 2008, for a total of 5 research publications in total.

Sherene S Ss Min Author Information

LAST NAME: min

FIRST NAME: Sherene S

INITIALS: ss

AFFILIATION:

Papers

Sherene S Min's Publication Record

1. Safety and Pharmacokinetics of GSK364735, a Human Immunodeficiency Virus Type 1 Integrase Inhibitor, following Single and Repeated Administration in Healthy Adult Subjects. Year Published: 2007
GlaxoSmithKline, 5 Moore Dr., Research Triangle Park, NC 27709. sherene.s.min@gsk.com.
2. Safety and pharmacokinetics of GSK364735, a human immunodeficiency virus type 1 integrase inhibitor, following single and repeated administration in healthy adult subjects. Year Published: 2007
GlaxoSmithKline, 5 Moore Dr., Research Triangle Park, NC 27709, USA.
3. Pharmacokinetic Interaction between Fosamprenavir-Ritonavir and Rifabutin in Healthy Subjects. Year Published: 2008
GlaxoSmithKline CPDM, Five Moore Drive, RTP, NC 27709. susan.l.ford@gsk.com.
4. Effect of omeprazole on the plasma concentrations of indinavir when administered alone and in combination with ritonavir. Year Published: 2008
Division of Pharmacotherapy and Experimental Therapeutics, School of Pharmacy, University of North Carolina, Chapel Hill 27599-7360, USA.
5. Pharmacokinetic interaction between fosamprenavir-ritonavir and rifabutin in healthy subjects. Year Published: 2008
Clinical Pharmacology and Discovery Medicine, GlaxoSmithKline, Research Triangle Park, NC 27709, USA. susan.l.ford@gsk.com